Verition Fund Management
HALO icon

Verition Fund Management’s Halozyme HALO Stock Holding History

Verition Fund Management’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-12,800
Closed -$227K – 793
2019
Q4 		$227K Hold
12,800
– – ﹤0.01% 925
2019
Q3 		$199K Buy
12,800
+100
+0.8% +$1.65K 0.01% 953
2019
Q2 		$218K Buy
+12,700
New +$205K 0.01% 953

Other funds holding HALO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Verition Fund Management's HALO Position: Q1 2026 in Review

Verition Fund Management sold out of Halozyme (HALO) in Q1 2026, closing a stake of 27,995 shares — an estimated $1.88M sold.

Verition Fund Management first reported a position in HALO in Q2 2014 and held it in 25 quarters. The position peaked at $5M in Q3 2025. 635 funds tracked by Wall St. Rank hold HALO as of Q1 2026.

  • Verition Fund Management reported no remaining Halozyme position as of Q1 2026 after selling out during the quarter.
  • Verition Fund Management sold 27,995 Halozyme shares in Q1 2026, an estimated $1.88M.
  • Verition Fund Management first reported a position in Halozyme in Q2 2014 and held it in 25 quarters.
  • Verition Fund Management's Halozyme position peaked at $5M in Q3 2025.
  • 635 funds tracked by Wall St. Rank held Halozyme as of Q1 2026.

Based on Verition Fund Management's 13F filing for Q1 2026, filed 15 May 2026.